Mackay Shields LLC’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-68,500
Closed -$2.81M 713
2021
Q1
$2.81M Sell
68,500
-45,400
-40% -$1.69M 0.02% 628
2020
Q4
$3.32M Buy
113,900
+10,900
+11% +$282K 0.02% 626
2020
Q3
$2.27M Sell
103,000
-7,700
-7% -$196K 0.02% 738
2020
Q2
$3.08M Sell
110,700
-21,300
-16% -$519K 0.02% 569
2020
Q1
$2.42M Buy
+132,000
New +$3.07M 0.02% 589
2018
Q2
Sell
-10,500
Closed -$258K 1194
2018
Q1
$258K Buy
+10,500
New +$276K ﹤0.01% 1196

Other funds holding ACLS

Mackay Shields LLC's ACLS Position: Q2 2021 in Review

Mackay Shields LLC sold out of Axcelis (ACLS) in Q2 2021, closing a stake of 68,500 shares — an estimated $2.81M sold.

Mackay Shields LLC first reported a position in ACLS in Q1 2018 and held it in 6 quarters. The position peaked at $3.32M in Q4 2020. 189 funds tracked by Wall St. Rank hold ACLS as of Q2 2021.

  • Mackay Shields LLC reported no remaining Axcelis position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 68,500 Axcelis shares in Q2 2021, an estimated $2.81M.
  • Mackay Shields LLC first reported a position in Axcelis in Q1 2018 and held it in 6 quarters.
  • Mackay Shields LLC's Axcelis position peaked at $3.32M in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Axcelis as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.